If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

New Trials

28 Apr 2008 08:09

Plant Health Care PLC28 April 2008 For immediate release 28 APRIL 2008 PLANT HEATH CARE PLC ("Plant Heath Care" or "the Company") Plant Health Care, Inc. initiates large scale grower tests for a ProActTM + Glyphosate product Plant Heath Care, (AIM: PHC.L), a leading provider of natural products forplants and soil, has initiated a large scale field trial program for corn,soybeans, and cotton to further evaluate the already established benefits ofusing ProActTM in combination with glyphosate, the world's most commonly usedherbicide, when applied over-the-top of glyphosate resistant crops. Five yearsof independent testing have demonstrated significant yield increases in cottonand corn when treated with a combination of ProAct and glyphosate. ProAct is afoliar spray product for reducing nematode populations and improving overallplant health. ProAct, which is the only foliar spray product labeled for useagainst nematodes in corn and soybeans, contains Harpin, a second generationharpin protein formulated as a wettable dry granule. PHC Director of Field Biology Ned French says, "ProAct increases yields. Thecomprehensive data from multi-year ProAct research shows average increases of2.5 bushels/acre in soybeans, 7 bushels/acre in corn, and 68 pounds of cottonlint/acre. These yield increases translate into economic returns of $28, $35,and $50/acre, respectively. The ProAct + Glyphosate Program will help bothgroups learn more about the benefits in real-world farming conditions." All participants will be asked to join a series of post-harvest teleconferencesto discuss how the ProAct + glyphosate tank-mix performed on their farms. PHCwill use the information gleaned from the teleconferences as the basis forbetter understanding farmer needs and perceptions as they relate to the use ofProAct + glyphosate. PHC, started in 1995, was originally focused on horticulture, turf, vegetablesand high value crops. The company started targeting field crops -corn, soybeans,and cotton - in 2007 based on its acquisition of harpin protein technologyproducts such as ProAct. ProAct contains the most recently developed andeffective generation of harpin proteins. Plant Health Care, Inc., headquartered in Pittsburgh, PA, is a wholly ownedsubsidiary of Plant Health Care plc (AIM:PHC), a leading provider of naturalproducts for plants and soil. PHC has operations in the United States, Mexico,the United Kingdom, Spain, and the Netherlands. PHC products are used in theagriculture, landscape, horticulture and land reclamation industries and areenvironmentally beneficial. Through the commercialization of these products, PHCis capitalizing on current long-term trends toward natural systems andbiological products for plant care and soil and water management. For moreinformation and complete details pertaining to the ProAct SatisfactionGuarantee, go to www.planthealthcare.com. -ends- For further information: Plant Heath Care plc John Brady, Chief Executive Tel: 001 603 525 3702 Evolution Securities Limited Tim Worlledge/ Tim Redfern Tel: 020 7071 4300 Tavistock Communications Jeremy Carey/Matt Ridsdale Tel: 020 7920 3150 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Oct 20122:00 pmRNSNotification of Major Interest in Shares
19th Oct 20123:10 pmRNSNotification of Major Interest in Shares
9th Oct 20127:00 amRNSStrong uptake of new product
8th Oct 20127:00 amRNSNotification of Major Interest In Shares
13th Sep 20127:00 amRNSSignificant progress in SA 2013 maize crop season
31st Aug 20125:00 pmRNSTotal Voting Rights
30th Aug 20122:47 pmRNSHolding(s) in Company
28th Aug 20129:40 amRNSPosting of Interim Report
24th Aug 20122:30 pmRNSDirector/PDMR Shareholding
20th Aug 201212:45 pmRNSAIM Blocklisting Interim Return
20th Aug 20127:00 amRNSHalf Yearly Report
14th Aug 20127:00 amRNSHolding(s) in Company
1st Aug 201212:15 pmRNSDirectorate Change
30th Jul 201212:15 pmRNSNotification of Major Interest in Shares
27th Jul 20127:00 amRNSPotato yield increased through PHC's Harpin
18th Jul 20127:00 amRNSHolding(s) in Company
17th Jul 20127:00 amRNSHolding(s) in Company
28th Jun 20127:00 amRNSHolding(s) in Company
17th May 20127:00 amRNSResearch cooperation with University of Arkansas
3rd May 201212:00 pmRNSHolding(s) in Company
1st May 20125:00 pmRNSTotal Voting Rights
27th Apr 201211:49 amRNSResearch Agreement with Arysta LifeScience
25th Apr 20122:45 pmRNSTR-1 Notification of Major Interest in Shares
20th Apr 20123:00 pmRNSTR-1 Notification of Major Interest in Shares
20th Apr 20127:00 amRNSResult of AGM
18th Apr 20127:00 amRNSTR-1 Notification of Major Interest in Shares
17th Apr 20128:23 amRNSDirector/PDMR Shareholding
13th Apr 20122:00 pmRNSDirectorate Change
5th Apr 20127:00 amRNSAgreement with MANA Crop Protection
23rd Mar 201210:30 amRNSHolding(s) in Company
21st Mar 20123:00 pmRNSHolding(s) in Company
19th Mar 20129:45 amRNSPublication of Annual Report
27th Feb 20129:30 amRNSChange of Adviser
27th Feb 20127:00 amRNSFinal Results
20th Feb 20121:30 pmRNSBlocklisting Interim Review
1st Feb 20127:00 amRNSDistribution deal with Agrium subsidiary
18th Jan 20127:00 amRNSTrading Update
11th Jan 201212:10 pmRNSHolding(s) in Company
3rd Jan 20124:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20124:35 pmRNSPrice Monitoring Extension
12th Dec 20117:00 amRNSProduct Update: Harpin
1st Dec 201112:45 pmRNSTotal Voting Rights
23rd Nov 20114:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20114:35 pmRNSPrice Monitoring Extension
10th Nov 20116:00 pmRNSHolding(s) in Company
10th Nov 20114:30 pmRNSHolding(s) in Company
14th Sep 20117:30 amRNSHolding(s) in Company
13th Sep 201111:00 amRNSHolding(s) in Company
8th Sep 20114:00 pmRNSHolding(s) in Company
1st Sep 201110:30 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.